These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9633842)

  • 41. IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer.
    Spentzos D; Cannistra SA; Grall F; Levine DA; Pillay K; Libermann TA; Mantzoros CS
    Endocr Relat Cancer; 2007 Sep; 14(3):781-90. PubMed ID: 17914107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The correlation of the World Health Organization histologic classification of thymic epithelial tumors and its prognosis: a clinicopathologic study of 108 patients from China.
    Honglin Yin ; Jun Du ; Zhenfeng Lu ; Xia Jiao ; Jiandong Wang ; Xiaojun Zhou
    Int J Surg Pathol; 2009 Jun; 17(3):255-61. PubMed ID: 19443889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.
    Harter P; du Bois A; Hahmann M; Hasenburg A; Burges A; Loibl S; Gropp M; Huober J; Fink D; Schröder W; Muenstedt K; Schmalfeldt B; Emons G; Pfisterer J; Wollschlaeger K; Meerpohl HG; Breitbach GP; Tanner B; Sehouli J; ;
    Ann Surg Oncol; 2006 Dec; 13(12):1702-10. PubMed ID: 17009163
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of DNA damage checkpoint protein Hus1 in epithelial ovarian tumors correlates with prognostic markers.
    de la Torre J; Gil-Moreno A; García A; Rojo F; Xercavins J; Salido E; Freire R
    Int J Gynecol Pathol; 2008 Jan; 27(1):24-32. PubMed ID: 18156970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival in ovarian cancer patients by histology and family history.
    Ji J; Försti A; Sundquist J; Lenner P; Hemminki K
    Acta Oncol; 2008; 47(6):1133-9. PubMed ID: 18607880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of risk factors for epithelial ovarian cancer recurrence].
    Liu S; Liu JH; Huang H; Peng XP; Wang YM
    Ai Zheng; 2003 Nov; 22(11):1197-200. PubMed ID: 14613652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
    Osman N; O'Leary N; Mulcahy E; Barrett N; Wallis F; Hickey K; Gupta R
    Ir Med J; 2008 Sep; 101(8):245-7. PubMed ID: 18990955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma.
    Khouja MH; Baekelandt M; Nesland JM; Holm R
    Int J Gynecol Pathol; 2007 Oct; 26(4):418-25. PubMed ID: 17885492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of borderline tumors of the ovary: state of the art.
    Tropé C; Kaern J
    Semin Oncol; 1998 Jun; 25(3):372-80. PubMed ID: 9633850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.
    ; Secord AA; Lee PS; Darcy KM; Havrilesky LJ; Grace LA; Marks JR; Berchuck A
    Gynecol Oncol; 2006 Jun; 101(3):390-7. PubMed ID: 16551475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma.
    Li AJ; Baldwin RL; Karlan BY
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3667-73. PubMed ID: 14506156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of lymphadenectomy and survival in stage I ovarian cancer patients.
    Chan JK; Munro EG; Cheung MK; Husain A; Teng NN; Berek JS; Osann K
    Obstet Gynecol; 2007 Jan; 109(1):12-9. PubMed ID: 17197582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.
    Gershenson DM; Deavers M; Diaz S; Tortolero-Luna G; Miller BE; Bast RC; Mills GB; Silva EG
    Clin Cancer Res; 1999 Dec; 5(12):4053-8. PubMed ID: 10632339
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prognostic factors in epithelial ovarian cancers--clinical significance of morphologic indicators].
    Gu MJ
    Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):437-40. PubMed ID: 2634543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Importance of clinical prognostic factors in the treatment of ovarian carcinoma].
    Spacek J; Petera J; Tesarík Z
    Ceska Gynekol; 2002 Sep; 67(5):280-5. PubMed ID: 12434665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of advanced epithelial cancer of the ovary: towards a change in practice?].
    Leblanc E; Narducci F; Querleu D; Morice P
    Bull Cancer; 2009 Dec; 96(12):1149-50. PubMed ID: 20050347
    [No Abstract]   [Full Text] [Related]  

  • 57. The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
    Khalil I; Brewer MA; Neyarapally T; Runowicz CD
    Gynecol Oncol; 2010 Feb; 116(2):282-5. PubMed ID: 19931138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting the response of advanced cervical and ovarian tumors to therapy.
    Harry VN; Gilbert FJ; Parkin DE
    Obstet Gynecol Surv; 2009 Aug; 64(8):548-60. PubMed ID: 19624866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Molecular characterization of epithelial ovarian borderline tumors with respect to clinical management and prognosis].
    Zikán M; Pinkavová I; Sláma J; Freitag P; Janousek M; Fischerová D; Pavlista D; Cibula D
    Ceska Gynekol; 2009 Dec; 74(6):427-30. PubMed ID: 21246790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Classification of surface epithelial neoplasms of the ovary.
    Hendrickson MR; Longacre TA
    Pathology (Phila); 1993; 1(2):189-254. PubMed ID: 9420920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.